Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Hold
100,000
﹤0.01% 5662
2026
Q1
$1.11M Sell
100,000
-364,000
-78% -$4.64M ﹤0.01% 5473
2025
Q4
$7.6M Buy
464,000
+384,000
+480% +$5.98M ﹤0.01% 3591
2025
Q3
$1.07M Sell
80,000
-340,800
-81% -$4.03M ﹤0.01% 5520
2025
Q2
$5.39M Sell
420,800
-89,600
-18% -$1.07M ﹤0.01% 3797
2025
Q1
$5.26M Buy
510,400
+509,400
+50,940% +$6.56M ﹤0.01% 3733
2024
Q4
$12.7K Buy
+1,000
New +$13.2K ﹤0.01% 8183
2024
Q2
Sell
-1,417,500
Closed -$32.1M 9948
2024
Q1
$32.1M Buy
+1,417,500
New +$33.2M 0.01% 1354
2023
Q1
Sell
-75,000
Closed -$953K 10164
2022
Q4
$953K Buy
+75,000
New +$927K ﹤0.01% 4122
2022
Q2
Sell
-80,000
Closed -$1.73M 10753
2022
Q1
$1.73M Sell
80,000
-60,000
-43% -$2.02M ﹤0.01% 3575
2021
Q4
$6.04M Buy
140,000
+100,000
+250% +$4.93M ﹤0.01% 2625
2021
Q3
$2.1M Buy
+40,000
New +$2.42M ﹤0.01% 3527

Other funds holding PATH

UBS Group's PATH Position: Q2 2026 in Review

UBS Group reduced its UiPath (PATH) stake by 14% in Q2 2026, selling an estimated $13.6M and leaving 8,132,417 shares worth $88.4M. The position accounts for 0.01% of the portfolio, ranked #1217.

UBS Group first reported a position in PATH in Q2 2021 and has held it in 21 quarters since. The position peaked at $471M in Q2 2025. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • UBS Group held 8,132,417 shares of UiPath worth $88.4M as of Q2 2026.
  • UBS Group sold 1,270,676 UiPath shares in Q2 2026, an estimated $13.6M.
  • UiPath made up 0.01% of UBS Group's portfolio in Q2 2026, its #1217 holding.
  • UBS Group first reported a position in UiPath in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's UiPath position peaked at $471M in Q2 2025.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.